Sonodynamic therapy doubled the median overall survival to 15.7 months and tripled progression-free survival to 5.5 months in ...

Both radiation and temozolomide, a generic chemotherapy treatment in pill form, have meaningful single-modality anti-tumor ...

Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distinguished ...

Glioblastoma, an aggressive brain cancer, syncs its internal clock to the host’s circadian rhythms, leveraging daily hormone ...

Glioblastoma survival has not improved in the last 30 years and there is an urgent need to develop novel therapeutic approaches for it.

This discovery is important because until now, we have not had compelling evidence that temozolomide improves overall survival in grade 2 gliomas." David Schiff, MD, lead investigator, the ...

Memorial Sloan Kettering Cancer Center-led researchers have identified a small molecule called gliocidin that kills ...

In an effort to understand what drives growth and recurrence of gliomas, researchers provide the first profile of the neurons that connect to them. Gliomas are the most common brain cancers. One type, ...

Researchers from Memorial Sloan Kettering Cancer Center and affiliated organizations revealed findings from the preclinical evaluation of 1H5, a novel monoclonal antibody (mAb) candidate that inhibits ...